![Mark Mckenna](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Mckenna
Vorsitzender bei APOGEE THERAPEUTICS, INC.
Vermögen: 915 000 $ am 30.06.2024
Ursprung des Netzwerks ersten Grades von Mark Mckenna
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Bausch & Lomb, Inc.
![]() Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.
64
| Subsidiary | Medical Specialties | 64 |
Subsidiary | Biotechnology | 28 | |
Public Company | Biotechnology | 19 | |
Public Company | Biotechnology | 16 | |
Prometheus Laboratories, Inc.
![]() Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Holding Company | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mark Mckenna
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Chief Executive Officer General Counsel Human Resources Officer | |
BRIDGEBIO PHARMA, INC. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal | |
ALLERGAN PLC | Pharmaceuticals: Major | Chief Executive Officer Public Communications Contact Director of Finance/CFO General Counsel Human Resources Officer | |
University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer Corporate Officer/Principal Chairman Sales & Marketing | |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Chief Executive Officer Investor Relations Contact Treasurer | |
AXCA HEALPAR | Biotechnology | Director/Board Member Director/Board Member General Counsel General Counsel | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Corporate Officer/Principal Human Resources Officer | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
University of Connecticut | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | Chief Executive Officer Investor Relations Contact Corporate Officer/Principal Comptroller/Controller/Auditor | |
University of California | College/University | Director/Board Member Doctorate Degree Undergraduate Degree | |
Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
University of California San Diego | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
PAYCHEX, INC. | Data Processing Services | Director of Finance/CFO Human Resources Officer Director of Finance/CFO | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
STAAR SURGICAL COMPANY | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
BAUSCH + LOMB CORPORATION | Medical Specialties | Chief Executive Officer Chief Executive Officer General Counsel | |
University of Rochester Simon Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
The Wharton School of the University of Pennsylvania | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
Bausch & Lomb BV
![]() Bausch & Lomb BV Electronic ComponentsElectronic Technology Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life. It offers the world's most comprehensive portfolio of eye health products and the proud that it is one of the oldest, best known and most respected healthcare brands in the world. The company began in 1853 in Rochester, New York, as a small optical shop that grew to become a multi-billion dollar corporation with nearly 14,000 employees worldwide, and with products available in more than 100 countries. | Electronic Components | Chief Executive Officer Director/Board Member Director/Board Member | |
Nestle Health Science SA
![]() Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Stanford University | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
PricewaterhouseCoopers LLP
![]() PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Advanced Medical Technology Association
![]() Advanced Medical Technology Association Miscellaneous Commercial ServicesCommercial Services Advanced Medical Technology Association is a trade association which provides medical technology solutions. The company was founded in 1974 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
SwanBio Therapeutics, Inc.
![]() SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
HydraFacial LLC
![]() HydraFacial LLC Other Consumer ServicesConsumer Services HydraFacial LLC provides aesthetic technologies and products. It offers HydraFacial MD serum-based hydradermabrasion systems. The company was founded by Roger G. Ignon and William Cohen in 1997 and is headquartered in Signal Hill, CA. | Other Consumer Services | Chief Executive Officer Chief Operating Officer | |
DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
QED Therapeutics, Inc.
![]() QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., QED Therapeutics, Inc. is a biotechnology company based in Palo Alto, CA. The company focuses on precision medicine for FGFR-driven diseases and is committed to finding solutions to FGFR-driven cancers and diseases to give patients more possibilities. QED Therapeutics' lead investigational candidate is infigratinib, an orally administered, FGFR1-3 selective tyrosine kinase inhibitor that has shown activity in patients with chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions and advanced urothelial carcinoma with FGFR3 genomic alterations. In 2020, QED submitted a new drug application (NDA) with the Food and Drug Administration for second- and later-line cholangiocarcinoma. Michael Henderson has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Texas A&M University | College/University | Graduate Degree Undergraduate Degree | |
Origin Biosciences, Inc.
![]() Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Origin Biosciences, Inc. is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The company is based in Palo Alto, CA. The company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector. Michael Henderson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
IMMUNE DESIGN CORP | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Boehringer Ingelheim Pharmaceuticals, Inc.
![]() Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Sales & Marketing Chief Executive Officer | |
Enterome SA
![]() Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Allergan Foundation | Director/Board Member President | ||
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Fairleigh Dickinson University | College/University | Undergraduate Degree Undergraduate Degree | |
Navire Pharma, Inc.
![]() Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Navire Pharma, Inc. engages in the development of therapeutics to treat multiple cancers. It focuses on SHP2, a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signalling with the downstream RAS/ERK MAPK pathway to regulate cellular proliferation and survival. The company was founded by Phil Jones and Benjamin Neel in 2017 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
Vereinigte Staaten | 42 |
Schweiz | 4 |
Kanada | 3 |
Irland | 2 |
Niederlande | 2 |
Sektoral
Health Technology | 31 |
Consumer Services | 15 |
Commercial Services | 3 |
Technology Services | 2 |
Electronic Technology | 2 |
Operativ
Director/Board Member | 471 |
Corporate Officer/Principal | 247 |
Independent Dir/Board Member | 151 |
Chief Executive Officer | 107 |
President | 107 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Brenton Saunders | 38 |
Anne Michelle Whitaker | 35 |
Flemming Ørnskov | 35 |
Ambrose Bailey | 32 |
Fred Hassan | 30 |
Catherine Burzik | 29 |
Domenico de Sole | 28 |
Scott Glenn | 28 |
Joseph Papa | 28 |
Linda Rice | 27 |
Alison Lawton | 25 |
Jane Henderson | 25 |
John Schmid | 24 |
Maria Hilado | 22 |
James Lightman | 22 |
- Börse
- Insiders
- Mark Mckenna
- Unternehmensverbindungen